Drug Trial Radar · NCT06229145
A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout
Last checked: Nov 20, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
306
Actual
Start
Mar 18, 2024
Primary completion
Jul 30, 2025
Study completion Mar 26, 2026
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Jan 29, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study consists of 24-week double-blind trial to evaluate the non-inferiority of the efficacy and safety of pegloticase Q4W with MTX versus pegloticase Q2W with MTX, followed by a 24-week open-label extension of pegloticase Q4W with MTX, in participants with uncontrolled refractory gout. The main objective of the study is to evaluate the effect of pegloticase 16 mg administered Q4W with MTX versus pegloticase 8 mg administered Q2W with MTX, on the response rate during Month 6, as measured by the sustained normalization of sUA to \< 6 mg/dL for at least 80% of the time.
Conditions
- Gout
Interventions
PegloticaseBiological
IV infusion
MethotrexateDrug
Oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Serum Uric Acid (sUA) Responders (sUA < 6 mg/dL) During Month 6Time frame: Month 6 (Weeks 20, 21, 22, 23, and 24)
Locations
74 sites in 1 country. Site status is shown where the registry gives one.
The University of Alabama at Birmingham (UAB)
Birmingham, Alabama
Orthopedic Physicians Alaska - Rheumatology and Infusion
Anchorage, Alaska
Arizona Arthritis and Rheumatology Associates - Chandler
Chandler, Arizona
Arizona Arthritis and Rheumatology Rese
Flagstaff, Arizona
Arizona Arthritis & Rheumatology Research, PLLC
Gilbert, Arizona
Arizona Arthritis & Rheumatology Research, PLLC
Mesa, Arizona
Arizona Arthritis and Rheumatology Research, PLLC
Mesa, Arizona
Arizona Arthritis and Rheumatology Research, PLLC
Phoenix, Arizona
Arizona Arthritis and Rheumatology Research
Phoenix, Arizona
Arizona Arthritis & Rheumatology Research, PLLC
Sun City, Arizona
Arizona Arthritis and Rheumatology
Tucson, Arizona
Covina Arthritis Clinic
Covina, California
Medvin Clinical Research- Riverside
Hemet, California
Velocity Clinical Research - Boise - ERN - PPDS
North Hollywood, California
TriWest Research Associates
San Diego, California
Precision Comprehensive Clinical Research Solutions
San Leandro, California
Saint John's Health Center - Providence St John's Health Ctr
Santa Monica, California
C.V. Mehta MD Medical Corporation
Temecula, California
Foothill Arthritis
Tujunga, California
Medvin Clinical Research
Whittier, California
University of Colorado Denver
Aurora, Colorado
Lynn Institute of the Rockies
Colorado Springs, Colorado
Denver Arthritis Clinic - Rheumatology
Denver, Colorado
Arthritis & Rheumatic Disease
Aventura, Florida
Prohealth Research Center
Doral, Florida
Life Clinical Trials
Margate, Florida
Homestead Associates in Research,Inc
Miami, Florida
D&H National Research Centers, Inc.
Miami, Florida
Well Pharma
Miami, Florida
Felicidad Medical Research, LLC.
Miami, Florida
New Generation Of Medical Research
Naples, Florida
IRIS Research & Development
Plantation, Florida
D&H Pompano Research Center
Pompano Beach, Florida
D&H Tamarac Research Center
Tamarac, Florida
GCP Clinical Research
Tampa, Florida
ClinPro Research Solutions, LLC
Tampa, Florida
Arthritis Center of North Georgia
Gainesville, Georgia
Vista Clinical Research, LLC
Newnan, Georgia
Great Lakes Clin. Trials
Chicago, Illinois
Conquest Research - Anesthesiology/Pain Medicine
Chicago, Illinois
Showing 40 of 74 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.